Saturday , 22 February 2025
0

No products in the cart.

Worldwide News Worldwide News
0

No products in the cart.

Home Health Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’
Health

Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’

October 24, 20241 Mins read42 Views
Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’

Radiant Biotherapeutics’ Multabodies are antibodies engineered to offer better binding strength to their targets. The preclinical startup’s lead program goes after a cancer immunotherapy target being pursued by several biotech companies already in early clinical development.

The post Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’ appeared first on MedCity News.

Previous post Gold surges amid geopolitical tensions as US yields fall

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

A paper by Proudman et al. (2024) finds that doing so would...

ByFebruary 22, 2025
Health

Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird...

ByFebruary 21, 2025

This fact sheet provides an overview of the history of the Kemp-Kasten...

ByFebruary 21, 2025

Katherine Saunders is the co-founder and CMO at FlyteHealth. She was one...

ByFebruary 21, 2025

Abous us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis

Subscribe Now

    Subscribe to our mailing list to receives daily updates direct to your inbox!
    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com